Friederike Braig Selected Research

Panitumumab (Vectibix)

1/2019	Nanobody Targeting of Epidermal Growth Factor Receptor (EGFR) Ectodomain Variants Overcomes Resistance to Therapeutic EGFR Antibodies.
5/2015	Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer.
11/2012	Functional dissection of the epidermal growth factor receptor epitopes targeted by panitumumab and cetuximab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Friederike Braig Research Topics

Disease

5	Neoplasms (Cancer) 01/2019 - 05/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2012
3	Squamous Cell Carcinoma of Head and Neck 01/2017 - 07/2016
1	COVID-19 01/2021
1	Substance-Related Disorders (Drug Abuse) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Bites and Stings (Sting) 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Multiple Myeloma 01/2016
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2015
1	Neoplasm Metastasis (Metastasis) 08/2014

Drug/Important Bio-Agent (IBA)

5	Cetuximab (Erbitux)FDA Link 01/2019 - 11/2012
5	ErbB Receptors (EGF Receptor)IBA 01/2019 - 11/2012
4	AntibodiesIBA 01/2019 - 11/2012
3	Panitumumab (Vectibix)FDA Link 01/2019 - 11/2012
3	EpitopesIBA 01/2017 - 05/2015
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 07/2016
1	SolutionsIBA 01/2021
1	blinatumomabIBA 01/2017
1	CD19 AntigensIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	PlatinumIBA 07/2016
1	Fluorouracil (Carac)FDA LinkGeneric 07/2016
1	Denosumab FDA Link 08/2014
1	Monoclonal AntibodiesIBA 08/2014

Therapy/Procedure

1	Immunotherapy 01/2017
1	Aftercare (After-Treatment) 01/2017
1	Radiotherapy 07/2016
1	Therapeutics 07/2016
1	Drug Therapy (Chemotherapy) 05/2015